Abstract:Clinical epidemiologic data and animal experimental studies regard estrogen as being protective against the development of cardiovascular diseases. The mechanisms by which estrogen affects the development of vascular diseases are not clear. Recent studies demonstrated that the cardiovascular protective effects of estrogen are closely related to nitric oxide (NO) pathway. Our previous study proved that estrogen inhibited the proliferation and oncogene expression of vascular smooth muscle cells (VSMCs) induced by endothlin 1 (ET-1) and serum,this effect was mediated by NO release. In the present study, we investigated the role of inducible nitric oxide synthase (iNOS) in the VSMCs cycle arrest induced by 17 beta-estradiol (E(2)). The effects of E(2) on iNOS activity and protein expression in cultured rat VSMCs and the influence of NOS inhibitor N(G)-nitro-L-arginine methylester (L-NAME) on the inhibitory effect of E(2) on cell cycle were investigated. NOS assay kit was used to measure the activity of iNOS and protein expression of iNOS was determined by Western-blot. Cell cycle analysis was accessed by flow cytometry. The results obtained showed that E(2) increased iNOS activity of VSMCs but not in a dose-dependent manner. E(2) 10 nmol/L increased the iNOS activity of VSMCs distinctly at two time points: 30 min and 12 h. These effects were significantly inhibited by estrogen receptor (ER) antagonist Tamoxifen (0.1 micromol/L) and NOS inhibitor L-NAME (1 micromol/L). E(2) increased iNOS protein expression of VSMCs in a dose-dependent manner. The effect of E(2) on iNOS protein expression of VSMCs started at 3 h, distinctly increased at 12 h and then decreased. Tamoxifen significantly inhibited the E(2)-induced iNOS protein expression of VSMCs. ET-1 increased cell percentage of S phase and G(2)+S/G(1). This effect was inhibited by E(2). L-NAME significantly attenuated the inhibitory effect of E(2) on cell cycle of VSMCs. The results suggest that E(2) induced G(1) arrest of VSMCs, which was associated with an increase in iNOS activity and protein expression of VSMCs. These effects were at least mediated by estrogen receptor partly.

[Effect of ERK on 17Beta-Estradiol-induced Inhibition of VSMC Proliferation in Rats after Vascular Injury].

[Inhibitory effects of emodin on proliferation of rat vascular smooth muscle cell induced by angiotensin II].

17β-Estradiol inhibits oleic acid-induced rat VSMC Proliferation and migration by restoring PGC-1α expression

Estradiol in inhibition of proliferation of vascular smooth muscle cells after balloon injury

17SS-Estradiol Antagonizes the Down-Regulation of ERα/NOS-3 Signaling in Vascular Endothelial Dysfunction of Female Diabetic Rats.

[Role of Inducible Nitric Oxide Synthase in the Vascular Smooth Muscle Cells Cycle Arrest Induced by 17 Beta-Estradiol].

Inhibitory effects of emodin on the proliferation of cultured rat vascular smooth muscle cell-induced by angiotensin II.

Pathogenesis of cardiovascular disease: Regulation of extracellular signal-regulated kinase on angiotensin II-induced proliferation of vascular smooth muscle cells

[Effect of 17Beta-Estradiol on Myocardial Inducible NOS and Endothelial NOS Activities after Ischemia-Reperfusion in Rat Heart Model].

Effect of estradiol on inhibition of neointimal p roliferation in rats after the lnjury of carotid arteries

17beta-estradiol inhibits oleic acid-induced rat VSMC proliferation and migration by restoring PGC-1alpha expression.

Effects of 17-β-Estradiol on Proliferation of Vascular Smooth Muscle Cells Induced by Thrombin and c-fos,Bcl-2 Expression

17Β-Estradiol Promotes Angiogenesis of Rat Cardiac Microvascular Endothelial Cells in Vitro.

17Β-Estradiol Potentiates Ischemia–reperfusion Injury in Diabetic Ovariectomized Female Rats

E0105 in Vitro Blockade of Oestrogen Receptor Promotes the Proliferation of Vascular Smooth Muscle Cells

Down-regulation of ETA receptor of vascular smooth muscle cells by 17 beta-estradiol]

Down-regulation of ETA receptor of vascular smooth muscle cells by 17β-estradiol

Dual effects of estrogen on vascular smooth muscle cells: receptor-mediated proliferative vs. metabolite-induced pro-senescent actions

The Analysis of the Inhibitied Effect of Estradiol/erα Pathway on the Transcription of Vascular Smooth Muscle SM22α

17Β-Estradiol Nongenomically Induces Vasodilation is Enhanced by Promoting Phosphorylation of Endophilin A2

Effect of estrogen on vascular endothelial growth factor expression in rat osteoblasts